1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Wesana Health Holdings Inc.
  6. Financials
    WESA   CA95081C1059

WESANA HEALTH HOLDINGS INC.

(WESA)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  01:18 2022-06-30 pm EDT
0.1850 CAD   +2.78%
06/08WESANA HEALTH CEO DANIEL CARCILLO TO KEYNOTE CHARLES RIVER SYMPOSIUM : Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
AQ
05/31Wesana Announces First Quarter 2022 Financial Results
AQ
05/31Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairman
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2021 2022 2023
Capitalization1 21,72,92-
Enterprise Value (EV)1 21,72,922,92
P/E ratio -0,76x-0,29x-0,28x
Yield ---
Capitalization / Revenue 81,1x1,87x1,07x
EV / Revenue 81,1x1,87x1,07x
EV / EBITDA -1,93x-0,17x-0,12x
Price to Book ---
Nbr of stocks (in thousands) 19 16220 305-
Reference price (USD) 1,130,140,14
Announcement Date 05/02/2022--
1 CAD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021 2022 2023
Net sales1 -0,271,562,74
EBITDA1 --11,2-17,1-25,0
Operating profit (EBIT)1 --11,3-21,8-30,4
Operating Margin --4 224%-1 398%-1 110%
Pre-Tax Profit (EBT)1 ---21,8-30,4
Net income1 -0,09-34,3-21,8-30,4
Net margin --12 851%-1 399%-1 110%
EPS2 -0,05-1,48-0,50-0,52
Dividend per Share ----
Announcement Date 05/10/202105/02/2022--
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 0,220,240,340,450,510,56
EBITDA1 -4,42-3,53-4,27-4,31-4,37-6,03
Operating profit (EBIT)1 -4,46-4,61-5,41-5,49-5,60-7,31
Operating Margin -2 012%-1 902%-1 599%-1 219%-1 107%-1 298%
Pre-Tax Profit (EBT)1 -22,7-4,85-5,41-5,49-5,60-7,31
Net income1 -22,7-4,85-5,41-5,49-5,60-7,31
Net margin -10 239%-2 005%-1 600%-1 220%-1 107%-1 299%
EPS2 -0,56-0,15-0,13-0,12-0,11-0,14
Dividend per Share ------
Announcement Date 05/02/202205/30/2022----
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023
Net Debt ----
Net Cash position ----
Leverage (Debt / EBITDA) ----
Free Cash Flow ----
ROE (Net Profit / Equities) ----
Shareholders' equity1 ----
ROA (Net Profit / Asset) ----
Assets1 ----
Book Value Per Share ----
Cash Flow per Share ----
Capex -0,02--
Capex / Sales -7,51%--
Announcement Date 05/10/202105/02/2022--
1 USD in Million
Estimates
Key data
Capitalization (CAD) 3 756 504
Capitalization (USD) 2 908 636
Net sales (USD) 267 210
Free-Float 99,1%
Free-Float capitalization (CAD) 3 721 515
Free-Float capitalization (USD) 2 881 544
Avg. Exchange 20 sessions (USD) 3 842
Average Daily Capital Traded 0,10%
EPS & Dividend